Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice

Molecular Pharmacology

Volumn 49, Issue 4, 1996, Pages 692-698

  Javitch, Jonathan A ^a   Fu, Dingyi ^a   Chen, Jiayun ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; 3 METHYLSPIPERONE; 3-N-METHYLSPIPERONE; BENZAMIDE DERIVATIVE; DRUG DERIVATIVE; EMONAPRIDE; SPIPERONE;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; CELL LINE; METABOLISM; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

BENZAMIDES; BINDING SITES; CELL LINE; CYSTEINE; HUMANS; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, DOPAMINE D2; SPIPERONE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029664506     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Civelli, O , J R. Bunzow, D. K. Grandy, Q.-Y. E. Zhou, and H. H. M. Van Tol. Molecular biology of the dopamine receptors. Eur. J. Pharmacol. 207:277-286 (1991).
2. Ostrowski, J., M. A. Kjelsberg, M. G. Caron, and R J. Lefkowitz. Mutagenesis of the β2-adrenergic receptor: how structure elucidates function. Annu. Rev. Pharmacol. Toxicol. 32:167-183 (1992).
3. Strader, C. D., T. M. Fong, M. K. Tola, D. Underwood, and R. A. F. Dixon. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:101-132 (1994).
4. Oprian, D. D. The ligand-binding domain of rhodopsin and other G protein-linked receptors. J. Bioenerget. Biomembr. 24:211-217 (1992).
5. Stauffer, D. A., and A. Karlin. The electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. Biochemistry 38:6840-6849 (1994).
6. Akabas, M. H., D. A. Stauffer, M. Xu, and A. Karlin. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science (Washington D. C.) 258:307-310 (1992).
7. Javitch, J. A., X. Li, J. Kaback, and A. Karlin. A cysteine residue in the third membrane-spanning segment of the human dopamine D2 receptor is exposed in the binding-site crevice. Proc. Natl. Acad. Sci. USA 91:10355-10359 (1994).
8. Javitch, J. A., D. Fu J. Chen, and A. Karlin. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method. Neuron 14:825-831 (1995).
9. Javitch, J. A., D. Fu, and J. Chen. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. Biochemistry 34:16433-16439 (1995).
10. Roberts, D. D., S. D. Lewis, D. P. Ballou, S. T. Olson, and J. A. Shafer. Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. Biochemistry 25:5595-5601 (1986).
11. Goldstein, A., and R. W. Barett. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion. Mol. Pharmacol. 31:603-609 (1987).
12. Strader, C. D., I. S. Sigal, R. B. Register, M. R. Candelore, E. Rands, and R. A. F. Dixon. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc. Natl. Acad. Sci. USA 84:4384-4388 (1987).
13. Strader, C. D , T. Gaffney, E. E. Sugg, M. R Candelore, R. Keys, A. A. Patchett, and R. A. F. Dixon. Allele-specific activation of genetically engineered receptors. J. Biol. Chem. 266:5-8 (1991).
14. 2 receptor. Eur. J. Pharmacol. 227:205-214 (1992).
15. Rognan, D., P. Sokoloff, A. Mann, M.-P. Martres, J.-C. Schwartz, J. Constentin, and C.-G. Wermuth. Optically active benzamides as predictive tools for mapping the dopamine D2 receptor. Eur. J. Pharmacol. 189: 59-70 (1990).
16. Woodward, E., P. Strange, and N. H. Naylor. The role of His394 in the binding of substituted benzamides to the rat D2 dopamine receptor. Biochem. Soc. Trans. 21:1138 (1993).
17. 3H]YM-09151-2. Naunyn-Schmiedeberg's Arch. Pharmacol. 329:333-343 (1985).
18. 3H]neuroleptic binding. Eur. J. Pharmacol. 144:163-171 (1987).
19. Javitch, J, A., J. Kaback, X. Li, and A. Karlin. Expression and characterization of human dopamine D2 receptor in baculovirus-infected insect cells. J. Recept. Res. 14:99-117 (1994).
20. Neve, K. A., B. A. Cox, R. A. Henningsen, A. Spanoyannis, and R. Neve. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol. 39:733-739 (1991).
21. 2 dopaminergic receptor subtype in a sodium-dependent manner. Mol. Pharmacol. 26:430-438 (1984).
22. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur. J. Pharmacol. 173:177-182 (1989).